Literature DB >> 28012245

Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.

Daisuke Tomizawa1,2, Akifumi Endo2, Michiko Kajiwara2, Hirotoshi Sakaguchi3, Kimikazu Matsumoto1,3, Makoto Kaneda4, Takashi Taga5.   

Abstract

Patients with Down syndrome (DS) are predisposed to acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in early and later childhood, respectively, but rarely experience both. We herein discuss four patients with DS with ALL and a history of AML who were treated with various chemotherapies, one of whom later received a bone marrow transplantation. Three patients survived and remain in remission. One patient died of fulminant hepatitis during therapy. No common cytogenetic abnormalities in AML and ALL besides constitutional +21 were identified, indicating that the two leukemia types were independent events. However, the underlying pathomechanism of these conditions awaits clarification.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Down syndrome; acute lymphoblastic leukemia; acute myeloid leukemia

Mesh:

Year:  2016        PMID: 28012245     DOI: 10.1002/pbc.26411

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  1 in total

Review 1.  Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.

Authors:  Brianna R Murphy; Michael Roth; E Anders Kolb; Todd Alonzo; Robert Gerbing; Robert J Wells
Journal:  Pediatr Blood Cancer       Date:  2019-03-25       Impact factor: 3.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.